Edity: Aurigene & Edity Enter Strategic Collaboration in Cell Therapy
Aurigene will provide discovery services to Edity to support its clinical development.
Read full article »
Edity is an Israel-based biotechnology company that develops a pre-clinical platform to deliver therapeutic proteins for the treatment of cancer, and genetic disorders.
Read more